百花医药：2025年前三季度净利润约3267万元

Group 1 - The core viewpoint of the article highlights the financial performance of Baihua Pharmaceutical in the third quarter of 2025, showing growth in revenue and net profit [1] - Baihua Pharmaceutical reported a revenue of approximately 299 million yuan for the first three quarters of 2025, representing a year-on-year increase of 2.74% [1] - The net profit attributable to shareholders was approximately 32.67 million yuan, reflecting a year-on-year increase of 36.41% [1] - The basic earnings per share were reported at 0.085 yuan, which is a year-on-year increase of 35.57% [1] Group 2 - As of the report, Baihua Pharmaceutical has a market capitalization of 3.7 billion yuan [2]